Related Experiment Video
Updated: Jul 27, 2026

08:19
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
17.9K
Key Design Features of Lipid Nanoparticles and Electrostatic Charge-Based Lipid Nanoparticle Targeting
Vijay Gyanani1, Roshan Goswami2
1T.J.L. School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.
Pharmaceutics
|April 28, 2023
Summary
Lipid nanoparticles (LNPs) are crucial for mRNA vaccines. This review details LNP design for efficacy, considering administration routes, targeting, and endosomal escape for improved drug delivery.
Area of Science:
- Biotechnology
- Nanomedicine
- Drug Delivery Systems
Background:
- Lipid nanoparticles (LNPs) have gained prominence due to mRNA COVID-19 vaccines.
- Ongoing clinical trials highlight the extensive research and development in LNP technology.
- Understanding fundamental LNP design is crucial for advancing therapeutic applications.
Purpose of the Study:
- To review key design aspects influencing LNP efficacy: potency, biodegradability, and immunogenicity.
- To discuss administration routes and targeting strategies for hepatic and non-hepatic delivery.
- To explore charge-based targeting for enhanced endosomal escape and cell internalization, particularly in tumor microenvironments.
Main Methods:
- Literature review of LNP design principles and applications.
- Analysis of factors affecting LNP performance, including formulation and administration.
- Examination of electrostatic interactions for optimizing drug release and cellular uptake.
Main Results:
- LNP efficacy is determined by potency, biodegradability, and immunogenicity.
- Targeting strategies are essential for both hepatic and non-hepatic delivery.
- Charge-based targeting can improve endosomal escape and cellular internalization in specific microenvironments.
Conclusions:
- Optimized LNP design is critical for successful therapeutic applications.
- Tailoring administration routes and targeting enhances LNP delivery efficiency.
- Electrostatic strategies offer potential for improving LNP-mediated drug release and cellular uptake.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

